Answers are grounded in this paper and cite their sources.
Introduction: Chronic kidney disease (CKD) is typically staged using population-derived empirical equations to estimate glomerular filtration rate (GFR) based on serum creatinine and/or cystatin C. However, these estimated GFR (eGFR) equations can be inaccurate for an individual patient. Although plasma-derived GFR using an exogenous agent is the preferred methodology, the requirement for multiple blood samples and laboratory analysis limits its practical clinical utility. We have shown that the fluorescent molecule, relmapirazin, is an exogenous GFR tracer agent and its transdermal fluorescence detection at the point-of-care can assess a clinically relevant range of GFR across all human skin colors. In the current study, transdermal GFR (tGFR) was compared with the plasma-derived indexed GFR (nGFR) in a multicenter pivotal clinical study. Methods: ). Results: of 96% was for participants with FSS I to III and 90% with IV to VI. Conclusion: values observed were in the optimal range as established by the 2024 Kidney Disease: Improving Global Outcomes guideline.
No takes yet. Share an insight, caveat, or question.
Dorshow et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: